Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress

References

• Aaron R, Gray R. “Osteonecrosis: etiology, natural history, pathophysiology, and diagnosis” In: Allaghan JJ, Rosenberg AG, Rubash H, editors. The adult hip. Philadelphia: Lippincott Williams & Wilkins; 2007:465–476.
   Google Scholar
• Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am 2012;41:595–611.
   PubMed Web of Science ®Google Scholar
• Camporesi EM, Vezzani G, Bosco G, et al. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty 2010;25:118–23.
   PubMed Web of Science ®Google Scholar
• Vezzani G, Camporesi EM, Mangar D, et al. Beneficial effect of hyperbaric oxygenation in avascular necrosis of the femoral head. Gazz. medica Ital Arch per le Sci mediche 2018;177:72–78.
   Web of Science ®Google Scholar
• Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med 2014;41:247–52.
   PubMed Web of Science ®Google Scholar
• Bosco G, Yang Z, Nandi J, et al. Effects of hyperbaric oxygen on glucose, lactate, glycerol and anti-oxidant enzymes in the skeletal muscle of rats during ischaemia and reperfusion. Clin Exp Pharmacol Physiol 2007;34:70–6.
   PubMed Web of Science ®Google Scholar
• Morabito C, Bosco G, Pilla R, et al. Effect of pre-breathing oxygen at different depth on oxidative status and calcium concentration in lymphocytes of scuba divers. Acta Physiol 2011;202:69–78.
   PubMed Web of Science ®Google Scholar
• Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 2009;106:988–95.
   PubMed Web of Science ®Google Scholar
• Asano T, Kaneko E, Shinozaki S, et al. Hyperbaric Oxygen Induces Basic Fibroblast Growth Factor and Hepatocyte Growth Factor Expression, and Enhances Blood Perfusion and Muscle Regeneration in Mouse Ischemic Hind Limbs. Circ J 2007;71, 405–11.
   PubMed Web of Science ®Google Scholar
• Milovanova TN, Bhopale VM, Sorokina EM, et al. Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J Appl Physiol 2009;106:711–28.
   PubMed Web of Science ®Google Scholar
• Vezzani G, Iezzi M, Rizzato A, et al. Effects of hyperbaric oxygen exposure on mobilization of endothelial progenitor cells in healthy volunteers. Acta Medica Mediterr 2017;33.
   Web of Science ®Google Scholar
• Mohamad JA, Kwan MK, Merican AM, et al. Early results of metal on metal articulation total hip arthroplasty in young patients. Med J Malaysia 2004;59: Suppl F:3–7.
   PubMedGoogle Scholar
• Kurokouchi K, Kambe F, Yasukawa K, et al. TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 1998;13:1290–9.
   PubMed Web of Science ®Google Scholar
• Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br 1985;67:3–9.
   PubMed Web of Science ®Google Scholar
• Vezzani G, Quartesan S, Cancellara P, et al. Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients. J Enzyme Inhib Med Chem 2017;32:707–11.
   PubMed Web of Science ®Google Scholar
• Mrakic-Sposta S, Gussoni M, Montorsi M, et al. A quantitative method to monitor reactive oxygen species production by electron paramagnetic resonance in physiological and pathological conditions. Oxid Med Cell Longev 2014;2014:306179.
   PubMed Web of Science ®Google Scholar
• Mrakic-Sposta S, Vezzoli A, Malacrida S, et al. Methods to detect oxidative stress during acute or chronic high-altitude exposure. High Alt Med Biol 2014;18:303–4.
   Web of Science ®Google Scholar
• Di Iorio A, Ferrucci L, Sparvieri E, et al. Serum IL-1beta levels in health and disease: a population-based study. ‘The InCHIANTI study]’. Cytokine 2003;22:198–205.
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001;86:1154–9.
   PubMed Web of Science ®Google Scholar
• Steeve KT, Marc P, Sandrine T, et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004;15:49–60.
   PubMed Web of Science ®Google Scholar
• Abu-Amer Y, Erdmann J, Alexopoulou L, et al. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Bill Chem 2000;275:27307–10.
   PubMed Web of Science ®Google Scholar
• Ohshima S, Saeki Y, Mima T, et al. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci 1998;95:8222.
   PubMed Web of Science ®Google Scholar
• De Benedetti F, Rucci N, Del Fattore A, et al. Impaired skeletal development in interleukin-6–transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 2006;54:3551–63.
   PubMed Web of Science ®Google Scholar
• Greenfeder SA, Nunes P, Kwee L, et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 1995;270:13757–65.
   PubMed Web of Science ®Google Scholar
• Baud V, Liu ZG, Bennett B, et al. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 1999;13:1297–308.
   PubMed Web of Science ®Google Scholar
• Jimi E, Nakamura I, Duong LT, et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 1999;247:84–93.
   PubMed Web of Science ®Google Scholar
• Polzer K, Joosten L, Gasser J, et al. Interleukin-1 is essential for systemic inflammatory bone loss. Ann Rheum 2010;69:284–90.
   PubMed Web of Science ®Google Scholar
• Panagakos FS, Jandinski JJ, Feder L, Kumar S. Effects of plasminogen and interleukin-1β on bone resorption in vitro. Biochimie 1994;76:394–7.
   PubMed Web of Science ®Google Scholar
• Nakase T, Takaoka K, Masuhara K, et al. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 1997;21:17–21.
   PubMed Web of Science ®Google Scholar
• Obando-Pereda GA, Fischer L, Stach-Machado DR. Titanium and zirconia particle-induced pro-inflammatory gene expression in cultured macrophages and osteolysis, inflammatory hyperalgesia and edema in vivo. Life Sci 2014;97:96–106.
   PubMed Web of Science ®Google Scholar
• Tipton DA, Seshul BA, Dabbous MK. Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J Periodontal Res 2011;46:39–47.
   PubMed Web of Science ®Google Scholar
• Camporesi EM, Bosco G. Hyperbaric oxygen pretreatment and preconditioning. Undersea Hyperb Med 2014;41:259–63.
   PubMed Web of Science ®Google Scholar